
LIMN vs CRIS
$LIMN vs $CRIS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
LIMN vs CRIS: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+3.2%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Neither kept up with the market over the past year: LIMN -94% and CRIS -98.1%, against the S&P 500 at +3.2%.
- ·The last month has flipped the order: CRIS leads over the month (+5.5% against -19.3%) even though LIMN leads over the year.
- ·CRIS has support 14.8% below at $0.37; LIMN has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
LIMN vs CRIS: the quick read
- ·CRIS is the larger company by market cap ($4M vs $3M).
- ·CRIS has been more active on our scanner (166 vs 2 alerts in 30 days).
- ·LIMN has the smaller float (1.1M vs 9.5M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·CRIS trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·CRIS draws far more of our scanner's attention, 166 unusual-volume alerts in 30 days against 2, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 20% of each other on market cap, which makes the rest of this table the interesting part.
- ·LIMN is the one in play today, trading about 2.1x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching LIMN or CRIS? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing LIMN and CRIS on TheDesperateTrader.
- Is LIMN or CRIS the better stock?
- "Better" depends on your goal, and these two are not alike. CRIS is the larger company by market cap ($4M vs $3M). CRIS has been more active on our scanner (166 vs 2 alerts in 30 days). LIMN has the smaller float (1.1M vs 9.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between LIMN and CRIS?
- The differences that matter: they are not in the same business - LIMN is biological products, (no diagnostic substances) and CRIS is biological products, (no diagnostic substances); they are similar in size ($3M vs $4M); they trade at very different share prices ($2.66 vs $0.43); LIMN sits at 44% of its 52-week range against 4% for CRIS; our scanner flagged LIMN 2 times in the last 30 days against 166 for CRIS. Everything above is measured from the latest completed session and SEC filings.
- Which of LIMN and CRIS is more active right now?
- Right now LIMN is at about 2.1x its normal volume and CRIS is at about 0.1x, so LIMN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is LIMN or CRIS in the stronger trend?
- LIMN is below its 50-day average of $3.27 and below its 200-day average of $8.11; CRIS is below its 50-day average of $0.69 and below its 200-day average of $7.71. LIMN leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading LIMN or CRIS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore LIMN and CRIS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.